Candriam S.C.A. Astrazeneca PLC Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $16.5 Million - $17.9 Million	-235,847 Reduced 38.79%	372,204 $26.6 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $600,430 - $680,772	9,508 Added 1.59%	608,051 $42.2 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $622,547 - $808,932	-11,484 Reduced 1.88%	598,543 $40.6 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $1.81 Million - $4.63 Million	-34,105 Reduced 5.29%	610,027 $33.5 Million
Q2 2022 Aug 03, 2022	SELL	$59.26 - $71.14 $13.9 Million - $16.6 Million	-233,728 Reduced 26.62%	644,132 $42.6 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $10.2 Million - $12.3 Million	-183,350 Reduced 17.28%	877,860 $58.2 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $1.77 Million - $2.09 Million	32,777 Added 3.19%	1,061,210 $61.8 Million
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $42.8 Million - $46.9 Million	771,047 Added 299.57%	1,028,433 $61.8 Million
Q2 2021 Jul 20, 2021	BUY	$48.42 - $60.18 $4.54 Million - $5.65 Million	93,802 Added 57.34%	257,386 $15.4 Million
Q1 2021 Apr 29, 2021	BUY	$47.16 - $54.44 $5,470 - $6,315	116 Added 0.07%	163,584 $7.86 Million
Q4 2020 Jan 22, 2021	BUY	$48.52 - $58.02 $2.15 Million - $2.57 Million	44,363 Added 37.25%	163,468 $8.17 Million
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $3.42 Million - $3.94 Million	64,419 Added 117.8%	119,105 $6.53 Million
Q2 2020 Jul 23, 2020	SELL	$43.1 - $55.31 $1.96 Million - $2.51 Million	-45,393 Reduced 45.36%	54,686 $2.89 Million
Q1 2020 May 26, 2020	BUY	$37.79 - $51.33 $2,380 - $3,233	63 Added 0.06%	100,079 $4.88 Million
Q4 2019 Jan 21, 2020	BUY	$42.46 - $50.46 $4.25 Million - $5.05 Million	100,016 New	100,016 $5,000
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $698,964 - $776,556	-21,200 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$32.09 - $34.78 $438,862 - $475,651	-13,676 Reduced 39.21%	21,200 $736,000
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $1.01 Million - $1.19 Million	34,876	34,876 $1.18 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.34 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.9 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.57 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.54 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.32 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account